Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
Noosa News11 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
General13 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists
-
Noosa News17 hours agoOn your marks, get set, buy!